Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).
about
Diet, exercise or diet with exercise: comparing the effectiveness of treatment options for weight-loss and changes in fitness for adults (18-65 years old) who are overfat, or obese; systematic review and meta-analysisRecent advances in central cardiovascular control: sex, ROS, gas and inflammationTestosterone Replacement Therapy and Prostate Cancer IncidenceEndocrine causes of nonalcoholic fatty liver diseaseChronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats.Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studiesTestosterone and weight loss: the evidence.Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.Testosterone therapy and mortality risk.Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).Testosterone and metabolic syndrome.Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.Transient Decrease in Circulatory Testosterone and Homocysteine Precedes the Development of Metabolic Syndrome Features in Fructose-Fed Sprague Dawley Rats.Transdermal testosterone replacement therapy in men.How to help the aging male? Current approaches to hypogonadism in primary care.Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study.Testosterone and obesity.Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both.Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.Impaired emotional state, quality of life and cognitive functions in young hypogonadal men.12-month observation of testosterone replacement effectiveness in a general population of men.Testosterone is protective against impaired glucose metabolism in male intrauterine growth-restricted offspring.Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men.EPHB6 and testosterone in concert regulate epinephrine release by adrenal gland chromaffin cells.The inter-relational effect of metabolic syndrome and sexual dysfunction on hypogonadism in type II diabetic men.
P2860
Q24288837-AF3C039D-93B0-4034-9F4C-8C535BAA2DD6Q26752442-2996C63E-6F3D-4937-A534-F86CEBACFE5BQ26771774-D8243B03-CE8B-40C7-834C-9F23F5399E03Q26780254-F1B448E4-67A6-4B00-8A07-2EC0073E99BEQ30389926-AF32204C-4B18-440E-BD42-EA8747FF16DAQ30983590-83239850-37D0-4158-821B-1869263B6972Q34134273-E7AA1493-5521-4C9D-8F32-30D28DD9067DQ34804834-F6F2309E-B25A-4686-A33A-EE135A8027FCQ35033737-1BF4B812-59C5-4FDB-96A7-49696101F0DAQ36196710-4C44C03C-D1F9-4C37-AB70-25634230A14AQ36293071-C15CF95D-547C-494A-AFDA-92E166C9FDC1Q37088526-D075611E-B915-466B-B0CF-31DCDAD060A2Q37366613-05B3BD12-1040-4C43-A513-DA7C0FB8251FQ37478020-20C672A6-3AB1-41FE-8DE1-5DEA0B398D98Q38052169-92248D45-F084-4145-B939-175B0EAE2BDBQ38402178-72D63739-5C6D-4171-8941-3FE07342DD7FQ38485746-25B61B0D-FBA5-4139-8669-B7191721ED70Q38569696-3C429603-A139-43FD-96A6-6E5C071C61DAQ42286793-D4D66BC3-E87A-48C1-A8E1-050BBF605E7DQ45021349-13991992-E4B2-472C-BD2B-1D292F2206C9Q45722782-D80966A9-2FC4-4A60-A478-F247C26A7721Q46494275-ACC2C3F4-3C41-4966-A3FA-A2539537DCC4Q47102977-025132DA-7F75-49F4-BE6D-33B194ECDA76Q47399627-8CF165FF-A674-4345-B7A0-DE131AD5BE62Q47552606-0E1B20B3-0C7C-4C81-906C-0B4AEB36E190Q48685313-DA12A47F-06FA-4228-ABA3-EB81C23DD732
P2860
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@ast
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@en
Effect of 12 months of testost ...... the Testim Registry in the US
@nl
type
label
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@ast
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@en
Effect of 12 months of testost ...... the Testim Registry in the US
@nl
prefLabel
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@ast
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@en
Effect of 12 months of testost ...... the Testim Registry in the US
@nl
P2093
P2860
P356
P1476
Effect of 12 months of testost ...... im Registry in the US (TRiUS).
@en
P2093
Dat Nguyen
Gary Blick
Harvey Kushner
Martin M Miner
Mohit Khera
Rajib K Bhattacharya
P2860
P2888
P356
10.1186/1472-6823-11-18
P577
2011-11-01T00:00:00Z
P5875
P6179
1024317999